N@N

Political shadows cast by the Antarctic curtain

The article from ScienceDaily discusses a study published in the journal Nature Communications, which explores the potential of using a common cold virus, specifically a modified strain of the Coxsackievirus B3 (CVB3), as a treatment for cancer. Researchers found that this virus can selectively target and kill cancer cells while leaving healthy cells unharmed. The study highlights how the virus triggers an immune response that not only destroys the cancer cells directly but also enhances the body's immune system to fight against remaining cancer cells. This approach could lead to new, less invasive cancer therapies, offering hope for treating various types of cancer, including those resistant to conventional treatments. The research also notes the virus's ability to spread within tumors, potentially overcoming one of the challenges in cancer virotherapy where viruses do not penetrate deeply enough into tumor masses.

Read the Full Science Daily Article at [ https://www.sciencedaily.com/releases/2024/11/241118130217.htm ]